Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif; Department of Mechanical Engineering, Stanford University, Stanford, Calif.
Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif; Department of Bioengineering, Stanford University, Stanford, Calif.
J Thorac Cardiovasc Surg. 2022 Oct;164(4):e133-e141. doi: 10.1016/j.jtcvs.2020.11.105. Epub 2020 Nov 30.
New transapical minimally invasive artificial chordae implantation devices are a promising alternative to traditional open-heart repair, with the potential for decreased postoperative morbidity and reduced recovery time. However, these devices can place increased stress on the artificial chordae. We designed an artificial papillary muscle to alleviate artificial chordae stresses and thus increase repair durability.
The artificial papillary muscle device is a narrow elastic column with an inner core that can be implanted during the minimally invasive transapical procedure via the same ventricular incision site. The device was 3-dimensionally printed in biocompatible silicone for this study. To test efficacy, porcine mitral valves (n = 6) were mounted in a heart simulator, and isolated regurgitation was induced. Each valve was repaired with a polytetrafluoroethylene suture with apical anchoring followed by artificial papillary muscle anchoring. In each case, a high-resolution Fiber Bragg Grating sensor recorded forces on the suture.
Hemodynamic data confirmed that both repairs-with and without the artificial papillary muscle device-were successful in eliminating mitral regurgitation. Both the peak artificial chordae force and the rate of change of force at the onset of systole were significantly lower with the device compared with apical anchoring without the device (P < .001 and P < .001, respectively).
Our novel artificial papillary muscle could integrate with minimally invasive repairs to shorten the artificial chordae and behave as an elastic damper, thus reducing sharp increases in force. With our device, we have the potential to improve the durability of off-pump transapical mitral valve repair procedures.
新型经心尖微创人工腱索植入装置为传统心脏修复提供了一种很有前途的替代方案,具有降低术后发病率和缩短康复时间的潜力。然而,这些装置可能会对人工腱索造成更大的压力。我们设计了一种人工乳头肌来减轻人工腱索的压力,从而提高修复的耐久性。
人工乳头肌装置是一种带有内芯的窄弹性柱体,可通过微创经心尖程序,通过相同的心室切口部位植入。该装置是为这项研究用生物相容性硅酮 3D 打印而成。为了测试疗效,将猪二尖瓣(n=6)安装在心脏模拟器中,并诱发孤立性反流。每个瓣膜均采用带有顶点锚固的聚四氟乙烯缝线进行修复,随后进行人工乳头肌锚固。在每种情况下,高分辨率光纤布拉格光栅传感器都会记录缝线的受力。
血流动力学数据证实,两种修复方法(有和没有人工乳头肌装置)均成功消除了二尖瓣反流。与顶点锚固而没有使用装置的情况相比,人工腱索的峰值力和收缩期开始时力的变化率都明显较低(P<0.001 和 P<0.001)。
我们新设计的人工乳头肌可以与微创修复相结合,缩短人工腱索并起到弹性阻尼器的作用,从而减少力的急剧增加。使用我们的装置,我们有可能改善非体外循环经心尖二尖瓣修复手术的耐久性。